Global Cord Blood Corporation (CORBF)

Market Cap	140.61M -4.5%
Revenue (ttm)	196.10M +7.2%
Net Income	79.03M -1.4%
EPS	0.65 -1.4%
Shares Out	133.91M
PE Ratio	1.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,232
Average Volume	2,372
Open	0.950
Previous Close	1.000
Day's Range	0.950 - 1.050
52-Week Range	0.200 - 1.750
Beta	-0.71
RSI	57.41
Earnings Date	n/a

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Stru...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: Ting Zheng
• Employees: 1,202
• Stock Exchange: OTCMKTS
• Ticker Symbol: CORBF

Financial Performance

In fiscal year 2022, Global Cord Blood's revenue was 1.24 billion, an increase of 7.21% compared to the previous year's 1.16 billion. Earnings were 501.07 million, a decrease of -1.41%.

Financial numbers in CNY